Mahmoud Eljalby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahmoud Eljalby has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Paul Cohen
Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA
2 shared publications Susan C. Pannullo
Department of Neurological Surgery, Weill Cornell Medicine, New York, NY
2 shared publications- Tobias Becher
Heidelberg University
2 shared publications - Alla Gabriella Wernicke
Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, USA
1 shared publication Allyn Mark
Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, USA
1 shared publicationAndreas G. Wibmer
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA
1 shared publication
Latest Publications
- Open Access
- 1 July 2021
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (7) , 100332
Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity
- 1 July 2021
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (7) , 100332
Open AccessBrown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity
- Top Cited Papers
- 4 January 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (1) , 58-65
Brown adipose tissue is associated with cardiometabolic health
White fat stores excess energy, whereas brown and beige fat are thermogenic and dissipate energy as heat. Thermogenic adipose tissues markedly improve glucose and lipid homeostasis in mouse models, although the extent to which brown adipose tissue (BAT) influences metabolic and cardiovascular disease in humans is unclear1,2. Here we retrospectively categorized 134,529 18F-fluorodeoxyglucose positron emission tomography–computed tomography scans from 52,487 patients, by presence or absence of BAT, and used propensity score matching to assemble a study cohort. Scans in the study population were initially conducted for indications related to cancer diagnosis, treatment or surveillance, without previous stimulation. We report that individuals with BAT had lower prevalences of cardiometabolic diseases, and the presence of BAT was independently correlated with lower odds of type 2 diabetes, dyslipidemia, coronary artery disease, cerebrovascular disease, congestive heart failure and hypertension. These findings were supported by improved blood glucose, triglyceride and high-density lipoprotein values. The beneficial effects of BAT were more pronounced in individuals with overweight or obesity, indicating that BAT might play a role in mitigating the deleterious effects of obesity. Taken together, our findings highlight a potential role for BAT in promoting cardiometabolic health.
- 4 January 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (1) , 58-65
Top Cited PapersBrown adipose tissue is associated with cardiometabolic health
White fat stores excess energy, whereas brown and beige fat are thermogenic and dissipate energy as heat. Thermogenic adipose tissues markedly improve glucose and lipid homeostasis in mouse models, although the extent to which brown adipose tissue (BAT) influences metabolic and cardiovascular disease in humans is unclear1,2. Here we retrospectively categorized 134,529 18F-fluorodeoxyglucose positron emission tomography–computed tomography scans from 52,487 patients, by presence or absence of BAT, and used propensity score matching to assemble a study cohort. Scans in the study population were initially conducted for indications related to cancer diagnosis, treatment or surveillance, without previous stimulation. We report that individuals with BAT had lower prevalences of cardiometabolic diseases, and the presence of BAT was independently correlated with lower odds of type 2 diabetes, dyslipidemia, coronary artery disease, cerebrovascular disease, congestive heart failure and hypertension. These findings were supported by improved blood glucose, triglyceride and high-density lipoprotein values. The beneficial effects of BAT were more pronounced in individuals with overweight or obesity, indicating that BAT might play a role in mitigating the deleterious effects of obesity. Taken together, our findings highlight a potential role for BAT in promoting cardiometabolic health.
- Open Access
- 10 August 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Cosmc controls B cell homing
The molecular mechanisms regulating lymphocyte homing into lymph nodes are only partly understood. Here, we report that B cell-specific deletion of the X-linked gene,Cosmc, and the consequent decrease of protein O-glycosylation, induces developmental blocks of mouse B cells. After transfer into wild-type recipient,Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs. Enzymatic desialylation of wild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-glycans for proper trafficking. Mechanistically,Cosmc-deficient B cells have normal rolling and firm arrest on high endothelium venules (HEV), thereby attributing their inefficient trafficking to alterations in the subsequent transendothelial migration step. Finally,Cosmc-null B cells have defective chemokine signaling responses. Our results thus demonstrate thatCosmcand its effects on O-glycosylation are important for controlling B cell homing.
- 10 August 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Open AccessCosmc controls B cell homing
The molecular mechanisms regulating lymphocyte homing into lymph nodes are only partly understood. Here, we report that B cell-specific deletion of the X-linked gene,Cosmc, and the consequent decrease of protein O-glycosylation, induces developmental blocks of mouse B cells. After transfer into wild-type recipient,Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs. Enzymatic desialylation of wild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-glycans for proper trafficking. Mechanistically,Cosmc-deficient B cells have normal rolling and firm arrest on high endothelium venules (HEV), thereby attributing their inefficient trafficking to alterations in the subsequent transendothelial migration step. Finally,Cosmc-null B cells have defective chemokine signaling responses. Our results thus demonstrate thatCosmcand its effects on O-glycosylation are important for controlling B cell homing.
- 1 July 2020
- Published by Elsevier in World Neurosurgery
- Vol. 139, e203-e211
Medical Students' Perceived Interests and Concerns for a Career in Neurosurgery
- 1 July 2020
- Published by Elsevier in World Neurosurgery
- Vol. 139, e203-e211
Medical Students' Perceived Interests and Concerns for a Career in Neurosurgery
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, 397-404
Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, 397-404
Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases
- Open Access
- 21 January 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 272 (1) , 113-117
Unique Considerations for Females Undergoing Esophagectomy
Objective: To improve understanding of sex differences in clinicopathologic characteristics, treatment and outcomes between male and female patients undergoing esophagectomy for esophageal cancer. Summary Background Data: Esophageal cancer is a male predominant disease, and sex has not been considered in previous studies as an important factor in diagnosis or management. Sex differences in demographics, clinicopathologic characteristics, and postoperative outcomes remain largely undefined. Methods: Retrospective review of 1958 patients (21% female) with esophageal cancer who underwent esophagectomy at a single institution between 1995 and 2017. Results: Most patients had adenocarcinoma (83%); however, the rate of squamous cell carcinoma was significantly higher in females (35% vs 11%, respectively; P < .0001). Females had a lower rate of smoking (62 vs 73%) and heavy alcohol use (12 vs 19%) but a higher rate of previous mediastinal radiation (8.4 vs 1.8%) (P < 0.001). Postoperative mortality and overall survival (OS) were similar between sexes. However, subanalysis of patients with locoregional disease (clinical stage II/III) demonstrated that females received neoadjuvant therapy less frequently than males and had worse OS (median OS 2.56 yrs vs 2.08; P = 0.034). This difference remained significant on adjusted analysis (HR 1.24, 95% CI 1.06–1.46). Conclusions: Female patients had higher incidence of squamous cell carcinoma despite lower prevalence of behavioral risk factors. Among patients with locoregional disease, undertreatment in females may reflect treatment bias and history of previous mediastinal radiation. Esophageal cancer in females should be considered a unique entity as compared with the presentation and treatment of males.
- 21 January 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 272 (1) , 113-117
Open AccessUnique Considerations for Females Undergoing Esophagectomy
Objective: To improve understanding of sex differences in clinicopathologic characteristics, treatment and outcomes between male and female patients undergoing esophagectomy for esophageal cancer. Summary Background Data: Esophageal cancer is a male predominant disease, and sex has not been considered in previous studies as an important factor in diagnosis or management. Sex differences in demographics, clinicopathologic characteristics, and postoperative outcomes remain largely undefined. Methods: Retrospective review of 1958 patients (21% female) with esophageal cancer who underwent esophagectomy at a single institution between 1995 and 2017. Results: Most patients had adenocarcinoma (83%); however, the rate of squamous cell carcinoma was significantly higher in females (35% vs 11%, respectively; P < .0001). Females had a lower rate of smoking (62 vs 73%) and heavy alcohol use (12 vs 19%) but a higher rate of previous mediastinal radiation (8.4 vs 1.8%) (P < 0.001). Postoperative mortality and overall survival (OS) were similar between sexes. However, subanalysis of patients with locoregional disease (clinical stage II/III) demonstrated that females received neoadjuvant therapy less frequently than males and had worse OS (median OS 2.56 yrs vs 2.08; P = 0.034). This difference remained significant on adjusted analysis (HR 1.24, 95% CI 1.06–1.46). Conclusions: Female patients had higher incidence of squamous cell carcinoma despite lower prevalence of behavioral risk factors. Among patients with locoregional disease, undertreatment in females may reflect treatment bias and history of previous mediastinal radiation. Esophageal cancer in females should be considered a unique entity as compared with the presentation and treatment of males.